Jett G K, Wilson E
Ann Emerg Med. 1984 Jun;13(6):462-4. doi: 10.1016/s0196-0644(84)80013-x.
Reported is the case of an anaphylactic reaction following sulindac ingestion. A 64-year-old man developed marked shortness of breath following the ingestion of a 200-mg sulindac tablet. On admission he had a palpable blood pressure of 50 mm Hg and diffuse inspiratory and expiratory wheezes on auscultation. He demonstrated marked cardiovascular instability for 24 hours following the adverse reaction. He was treated successfully with a continuous intravenous infusion of epinephrine, a corticosteroid, and an antihistamine. Recovery was complete. This case demonstrates that caution is needed in prescribing sulindac and other nonsteroidal anti-inflammatory drugs.
报告了一例服用舒林酸后发生过敏反应的病例。一名64岁男性在服用一片200毫克舒林酸片剂后出现明显的呼吸急促。入院时,他的收缩压为50毫米汞柱,听诊可闻及弥漫性吸气和呼气哮鸣音。不良反应发生后,他出现了24小时的明显心血管不稳定。通过持续静脉输注肾上腺素、一种皮质类固醇和一种抗组胺药,他得到了成功治疗,完全康复。该病例表明,开具舒林酸和其他非甾体抗炎药时需要谨慎。